BioStem secures USD 40 million equity facility via private placement with Roth affiliate - BSEM News | RalliesBioStem secures USD 40 million equity facility via private placement with Roth affiliate
B
BSEM• Committed equity facility with Roth Principal Investments
- BioStem Technologies entered a committed equity facility for up to USD 40 million with Roth Principal Investments via a private placement.
- The facility lets BioStem sell common stock to Roth at its discretion, subject to conditions including an effective resale registration statement.
- Issuance is capped at 19.99% of shares outstanding at signing unless shareholder approval is obtained or Nasdaq minimum-price rules are met.
- Net proceeds are intended for working capital and general corporate purposes.
•
